Rombotis Spiro George

Average Profitability
<0.0001%
Insider Buys Quantity
32
Insider Buys Sum
$819,074.64
Insider Sells Quantity
1
Insider Sells Sum
$20,875.00

Insider Activity of Rombotis Spiro George

According to the SEC Form 4 filings, Rombotis Spiro George, being in a position of

  1. President and CEO at Cyclacel Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 6070 shares for $20,122, and sold 0 shares,
    over all time since 2006-04-17, has bought 360904 shares for $819,075, and sold 8350 shares for $20,875.

The largest purchase of all time was on 2013-05-21 and amounted to 200000 shares of Cyclacel Pharmaceuticals, Inc. for $600,000.

The largest sale of all time was on 2010-04-23 and amounted to 8350 shares of Cyclacel Pharmaceuticals, Inc. for $20,875.

Biography of Rombotis Spiro George

No biography is available at this moment.

2023-12-21PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
6,070
0.6595%
$3.31$20,122-42.5%
2013-05-21PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
200,000
1.4075%
$3.00$600,000+16.94%
2011-12-23PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
15,902
0.0288%
$0.49$7,871+16%
2011-09-23PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
24,100
0.0453%
$0.51$12,171+11.43%
2011-09-22PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
5,000
0.01%
$0.59$2,965+0.65%
2011-09-13PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
12,400
–
$0.75$9,343-23.61%
2011-08-22PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
9,232
0.0171%
$0.73$6,721-21.92%
2010-04-23SaleCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
8,350
0.0238%
$2.50$20,875-34.17%
2008-12-02PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
3,000
0.0147%
$0.37$1,110+121.62%
2008-11-20PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
900
0.0046%
$0.31$280+171.67%
2008-11-19PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
8,000
0.044%
$0.35$2,840+154.69%
2008-11-18PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President & C.E.O.
17,000
0.0879%
$0.47$7,922+85.23%
2008-11-17PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President & C.E.O.
2,000
0.0083%
$0.50$1,000+38.14%
2008-08-19PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
8,900
0.0438%
$1.71$15,219-63.24%
2008-08-18PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
100
0.0005%
$1.76$176-64.69%
2008-06-05PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
5,000
0.0247%
$2.02$10,090-69%
2008-06-04PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
5,000
0.0247%
$2.02$10,090-69%
2008-05-21PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
7,500
0.0375%
$2.30$17,235-72.44%
2008-05-20PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
5,000
0.0245%
$2.35$11,755-73.62%
2008-05-15PurchaseCyclacel Pharmaceuticals, Inc.
CYCC
President and CEO
5,000
0.0244%
$2.49$12,430-75.1%
Company
About Prismo.proPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.